427 related articles for article (PubMed ID: 29565457)
1. Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).
Nikolouzakis TK; Vassilopoulou L; Fragkiadaki P; Mariolis Sapsakos T; Papadakis GZ; Spandidos DA; Tsatsakis AM; Tsiaoussis J
Oncol Rep; 2018 Jun; 39(6):2455-2472. PubMed ID: 29565457
[TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase in the clinical management of colorectal cancer.
Piñol-Felis C; Fernández-Marcelo T; Viñas-Salas J; Valls-Bautista C
Clin Transl Oncol; 2017 Apr; 19(4):399-408. PubMed ID: 27761787
[TBL] [Abstract][Full Text] [Related]
3. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
4. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.
Safont MJ; Gil M; Sirera R; Jantus-Lewintre E; Sanmartín E; Gallach S; Caballero C; Del Pozo N; Palomares E; Camps C
Clin Transl Oncol; 2011 Jun; 13(6):396-400. PubMed ID: 21680300
[TBL] [Abstract][Full Text] [Related]
6. Proteogenomic biomarkers in colorectal cancers: clinical applications.
Binetti M; Lauro A; Vaccari S; Cervellera M; Tonini V
Expert Rev Proteomics; 2020 May; 17(5):355-363. PubMed ID: 32536221
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
Fernández-Marcelo T; Sánchez-Pernaute A; Pascua I; De Juan C; Head J; Torres-García AJ; Iniesta P
PLoS One; 2016; 11(2):e0149626. PubMed ID: 26913901
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
Fadaka AO; Pretorius A; Klein A
Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
[TBL] [Abstract][Full Text] [Related]
9. The mechanisms and clinical significance of PDCD4 in colorectal cancer.
Long J; Yin Y; Guo H; Li S; Sun Y; Zeng C; Zhu W
Gene; 2019 Jan; 680():59-64. PubMed ID: 30243936
[TBL] [Abstract][Full Text] [Related]
10. Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.
Bertorelle R; Briarava M; Rampazzo E; Biasini L; Agostini M; Maretto I; Lonardi S; Friso ML; Mescoli C; Zagonel V; Nitti D; De Rossi A; Pucciarelli S
Br J Cancer; 2013 Feb; 108(2):278-84. PubMed ID: 23322193
[TBL] [Abstract][Full Text] [Related]
11. Telomeres, telomerase and colorectal cancer.
Bertorelle R; Rampazzo E; Pucciarelli S; Nitti D; De Rossi A
World J Gastroenterol; 2014 Feb; 20(8):1940-50. PubMed ID: 24616570
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs in colorectal cancer: Biomarkers to therapeutic targets.
Chen LJ; Chen X; Niu XH; Peng XF
Clin Chim Acta; 2023 Mar; 543():117305. PubMed ID: 36966964
[TBL] [Abstract][Full Text] [Related]
13. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy.
Yang Y; Meng WJ; Wang ZQ
Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1211-1226. PubMed ID: 32370729
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as potential investigative and predictive biomarkers in colorectal cancer.
Yaghoubi N; Zahedi Avval F; Khazaei M; Aghaee-Bakhtiari SH
Cell Signal; 2021 Apr; 80():109910. PubMed ID: 33387618
[TBL] [Abstract][Full Text] [Related]
17. Telomere maintenance in interplay with DNA repair in pathogenesis and treatment of colorectal cancer.
Tomasova K; Kroupa M; Forsti A; Vodicka P; Vodickova L
Mutagenesis; 2020 Jul; 35(3):261-271. PubMed ID: 32083302
[TBL] [Abstract][Full Text] [Related]
18. The Incredible Potential of Exosomes as Biomarkers in the Diagnosis of Colorectal Cancer.
Bhattacharya S
Curr Drug Res Rev; 2022; 14(3):188-202. PubMed ID: 35490434
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery.
Sattar RSA; Verma R; Nimisha ; Kumar A; Dar GM; Apurva ; Sharma AK; Kumari I; Ahmad E; Ali A; Mahajan B; Saluja SS
Cell Signal; 2022 Nov; 99():110413. PubMed ID: 35907519
[TBL] [Abstract][Full Text] [Related]
20. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways.
Esmaeili M; Keshani M; Vakilian M; Esmaeili M; Peymani M; Seyed Forootan F; Chau TL; Göktuna SI; Zaker SR; Nasr Esfahani MH; Ghaedi K
Gene; 2020 Aug; 753():144796. PubMed ID: 32450203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
